Navigation Links
The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure
Date:5/18/2009

continue to implement our long-term strategic plan and work to realize the potential of Pharma's QR-333 compound to treat Diabetic Peripheral Neuropathy and other formulations currently under development by the Company's Pharma division, management and our Board of Directors have determined that we should examine all potential means for maximizing value for our stockholders. Due to the current broad economic decline in the overall HBC category (Health and Beauty Care) marketplace, in both dollar and unit sales, a segment of the market into which cold remedies such as COLD-EEZE falls, we foresee no sign of immediate improvement. Therefore, we are taking the additional steps announced today to more closely align our operating costs with the current decreased level of demand for the Company OTC products."

The Company cautions that there can be no assurance that the exploration of strategic alternatives will result in any specific transaction. The Company does not expect to disclose further developments regarding the process until the completion of the strategic alternatives review and a decision by the Board of Directors regarding a transaction or course of action.

About The Quigley Corporation

The Quigley Corporation (Nasdaq: QGLY, http://www.Quigleyco.com) is a diversified natural health medical science company. Its Cold Remedy segment is a leading marketer and manufacturer of the COLD-EEZE(R) family of lozenges, gums and sugar free tablets clinically proven to cut the common cold nearly in half. COLD-EEZE customers include leading national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. The Quigley Corporation has several whol
'/>"/>

SOURCE The Quigley Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Judge Rejects Quigleys Claims - Karkus Director Candidates Prevail in Federal Court
2. Quigley Corporation Receives Support from Leading Independent Proxy Advisory Firms; RiskMetrics and Glass Lewis Reject Dissident Stockholder Ted Karkus, Citing Failure to Provide Detailed Business Plan
3. The Quigley Corporation Issues Open Letter to Stockholders; Urges Stockholders to Reject Dissident Ted Karkus Solicitation Efforts
4. The Quigley Corporation Reports First Quarter 2009 Results
5. Unexpected Positive Finding Expands Potential for Quigley QR333 Drug for Diabetic Neuropathy; Findings Suggest Possible Disease Modification
6. The Quigley Corporation Reports Fourth Quarter and 2008 Annual Results; Continues To Invest In Pharmaceutical R&D Future
7. Quigley Announces Completion of Phase IIb Clinical Study of QR-333 For Diabetic Peripheral Neuropathy on November 25, 2008; Collection and Evaluation of Study Data to Begin Immediately Thereafter
8. The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future
9. The Quigley Corporation Names Gerard M. Gleeson to Succeed Retiring George J. Longo as Chief Financial Officer and Director
10. The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future
11. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Miami Beach, Florida (PRWEB) February 27, 2015 ... largest non-profit organization devoted exclusively to funding innovative lymphoma ... series of education programs, outreach initiatives and patient services ... the South Florida community, returning to the greater Miami ... the La Gorce Country Club in Miami Beach on ...
(Date:2/27/2015)... "After studying the benefits and risks to ... spina bifida repair may outweigh the risks for those moms ... says Fetal Care Institute Director Dr. Mike Vlastos, ... "The goal of the study is to gain an ... their unborn babies." , Studies have shown that mothers with ...
(Date:2/27/2015)... Over 440,000 patients die annually as a result of ... jet airplanes crashing each day. Now more than ever before, ... to do all they can to stay safe. , Through ... U.S. Surgeon General, discusses the importance of safer hospitals. “It’s ... safety issues to ensure that all our patients are in ...
(Date:2/27/2015)... Jupiter Medical Center and The Mount Sinai Hospital ... York at Jupiter Medical Center, to enhance cardiac patient ... “This innovative collaboration with Mount Sinai Heart New York ... in our very own backyard,” said John D. Couris, ... “This kind of innovative thinking will transform cardiac care ...
(Date:2/27/2015)... 27, 2015 Muscular Dystrophy Association ... Engineering at Duke University, recently announced a potentially ... young men with Duchenne muscular dystrophy (DMD). The ... and Gersbach will discuss their implications at MDA's ... in Washington, D.C. , Background: Gersbach and ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Returns to Miami Beach For Exclusive Swirl Wine Tasting Event 2Health News:Pregnant Women with a BMI above 35 Now Eligible for Fetal Spina Bifida Repair Surgery Study at the St. Louis Fetal Care Institute 2Health News:Pregnant Women with a BMI above 35 Now Eligible for Fetal Spina Bifida Repair Surgery Study at the St. Louis Fetal Care Institute 3Health News:Dr. Richard Carmona, the 17th U.S. Surgeon General, and IntelliCentrics Raise Awareness in Mediaplanet’s “Patient Safety” Campaign 2Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 2Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 3Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 4Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 5Health News:Statement: New MDA-Funded Genetic Therapy Technique Targets DMD 2
... lid on brain injuries and deaths , SATURDAY, May ... Americans start to dust off their bikes, blades and ... trying to direct public attention toward the importance of ... "People are riding bicycles, motorcycles and ATVs [all-terrain vehicles] ...
... ... excited to once again team up with the Arthritis Foundation! On ... – Former Heavyweight Champion Evander Holyfield and U.S. Track and Field Champion ... raise awareness -- because they both have very personal stories about how ...
... Canada, in stark contrast with the rest of the world, ... extra dollar they make. The new study was led by ... Department of Sociology, and presented at the annual conference of ... spared by this correlation, but results are ambiguous," says Dumas. ...
... MA -- Harvard School of Public Health (HSPH) researchers ... blood cells by malaria parasites have instead succeeded in ... the disease. The findings reveal an essential step ... malaria parasite, Plasmodium falciparum , and offer a ...
... found in March no health risk, agency says , FRIDAY, ... vaccine Rotarix to prevent rotavirus, a common cause of severe ... Friday. , On March 22, the FDA recommended that ... two brands available to prevent rotavirus -- because doses appeared ...
... Study found severe injuries dropped after federally mandated worker ... research shows that a federal policy that requires miners ... permanently disabling injuries. , However, implementation of the regulation ... at stone, sand and gravel operations, according to a ...
Cached Medicine News:Health News:At Any Age, Helmets Make Riding Safer 2Health News:O2 Media's Hit Morning Show ‘The Balancing Act' Welcomes the Arthritis Foundation to the Program 2Health News:O2 Media's Hit Morning Show ‘The Balancing Act' Welcomes the Arthritis Foundation to the Program 3Health News:Men with bigger wallets have bigger waistlines 2Health News:New twist on potential malaria drug target acts by trapping parasites in cells 2Health News:New twist on potential malaria drug target acts by trapping parasites in cells 3Health News:Doctors Can Use Rotavirus Vaccine Again: FDA 2Health News:Safety Training Makes for Safer Mining 2Health News:Safety Training Makes for Safer Mining 3
(Date:2/27/2015)... 27, 2015  Following a bipartisan vote in ... H.R. 284, the Medicare DMEPOS Competitive Bidding Improvement ... Homecare (AAHomecare) released a statement praising the Committee,s ... the legislation. "Today,s mark-up of the ... and Means Committee is a critical step forward ...
(Date:2/27/2015)... 27, 2015 ... sistema di monitoraggio dell,infarto congestizio (CHF - Congestive ...     Vectorious Medical ... sistema per il monitoraggio cardiaco destinato a pazienti ... di aver concluso una raccolta di finanziamenti per ...
(Date:2/27/2015)... , Feb. 27, 2015 Securities lawyers at ... of Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP ) ... share. Concerned SLXP investors are encouraged to contact attorney ... The investigation focuses upon the shareholder value of ... shareholders would receive only $158.00 per share in cash. ...
Breaking Medicine Technology:Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2
... 14, 2011 WaferGen Biosystems, Inc. (OTC Bulletin Board: ... systems, today reported financial results for the three months and ... revenue growth in 2010 to a total of $2.2 million ... $1.5 to $2 million for the year," said Alnoor Shivji, ...
... Inc. (Nasdaq: BNVI ) announced today that it will ... ended December 31, 2010 on Tuesday, March 15, 2011. The Company ... results on Tuesday, March 15, 2011, at 5:30 p.m. ET. ... can listen via a live audio only webcast, which can be ...
Cached Medicine Technology:WaferGen Reports Fourth Quarter and Full Year 2010 Financial Results 2WaferGen Reports Fourth Quarter and Full Year 2010 Financial Results 3WaferGen Reports Fourth Quarter and Full Year 2010 Financial Results 4WaferGen Reports Fourth Quarter and Full Year 2010 Financial Results 5WaferGen Reports Fourth Quarter and Full Year 2010 Financial Results 6WaferGen Reports Fourth Quarter and Full Year 2010 Financial Results 7WaferGen Reports Fourth Quarter and Full Year 2010 Financial Results 8